THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Drug makers' suppliers may have to merge

To cut costs, many firms opt to deal with fewer vendors

By Todd Wallack
Globe Staff / February 18, 2008

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

When Charles River Laboratories Inc. chief executive James C. Foster looks across Massachusetts, he sees a string of major companies supplying drug firms with services and equipment. (Full article: 677 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass